Ligand validation:2AG9

MYR: MYRISTIC ACID

MYR is a Ligand Of Interest in 2AG9 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2AG9_MYR_B_3045	70%	77%	0.096	0.912	0.37	0.54	-	-	1	0	100%	0.75
2AG2_MYR_C_3045	7%	76%	0.21	0.656	0.41	0.54	-	-	0	0	100%	1
2AF9_MYR_A_3045	3%	81%	0.296	0.61	0.31	0.5	-	-	2	0	100%	1
8Q2Z_MYR_C_201	93%	68%	0.081	0.975	0.46	0.77	-	-	0	0	100%	0.9375
6NOK_MYR_A_401	92%	52%	0.077	0.967	0.71	1.14	-	2	0	0	100%	1
8Q3D_MYR_D_101	92%	65%	0.086	0.975	0.53	0.81	-	-	0	0	100%	0.9375
4LB9_MYR_A_602	89%	60%	0.068	0.947	0.59	0.94	-	1	2	0	100%	1
7OWO_MYR_D_401	88%	73%	0.088	0.962	0.45	0.59	-	-	0	0	100%	0.525

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.